Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Arthritis is THE future market
View:
Post by mstrmnd on Jul 20, 2021 4:36pm

Arthritis is THE future market

Muscle and fitness addictions are going to drive a huge rise in the future degenerative osteoarthritis market...this is THE future market and ATE.TO is incredibly well-positioned to not just be a part of it, but completely dominate it

Hold the line & say yes to vote out Dan at AGM

GLTA
Comment by 123ABC on Jul 20, 2021 4:42pm
Even the MasterPumper wants Dan out damn..
Comment by mstrmnd on Jul 20, 2021 4:47pm
Are you stupid?  Sell your shares and move on
Comment by MrMugsy on Jul 20, 2021 6:08pm
Hahaha!  Now that's the best comment I've heard here in a while Mstrmnd.
Comment by mstrmnd on Jul 20, 2021 6:30pm
The market cap of ATE.TO should reflect penetration into mild, moderate, and severe Osteoarthritis in both prescription and non-prescription markets Arthritis is THE future market In 10-20 years, all the muscle and fitness junkies of present are going to be writhing in pain from degenerative osteoarthritis...
Comment by yurejo on Jul 21, 2021 12:54am
This post has been removed in accordance with Community Policy
Comment by Forestview on Jul 21, 2021 8:53am
This is the fourth time this article was posted.  There's no mention of ATE, so I don't get why people are posting it.  What am I missing?
Comment by woundedknee on Jul 21, 2021 9:16am
Looke like a slick promotion which has nothing to do with Antibe.
Comment by Layth1990 on Jul 21, 2021 9:23am
I guess they are bots 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse